LGND
LIGAND PHARMACEUTICALS INC · Healthcare · Market cap $6.3B
Insiders sold $16.1M net in the last 90 days ·4 sellers, 0 buyers· 4 of 6 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 6, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$34.7M
reported sales (SEC code S)
Unique Insiders
9
in the rolling window
Latest filing
Oct 6, 2026
Reardon Andrew
LIGAND PHARMACEUTICALS INC (LGND) has 51 SEC Form 4 filings (205 transaction rows) in the rolling window, disclosed by 9 distinct insiders. Most recent filing: Oct 6, 2026.
Inside the rolling window, 9 insiders at LIGAND PHARMACEUTICALS INC reported no open-market purchases and 33 open-market sales totaling $34.7M. The most active filer is Director KOZARICH JOHN W with 9 filings. Insiders have net sold $25.1M over the trailing 6 months. The most recent open-market filing is a sale of 5,000 shares by CLO & Secretary Reardon Andrew, dated Oct 2, 2026, worth $1.5M.
- Industry:Biotechnology
- CEO:Todd C. Davis
- Employees:47
- HQ:Jupiter, FL, US
- IPO:1992-11-18
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CLO & Secretary | Sale | 5,000 | $1.5M | Oct 6 | +6.0% | SEC ↗ | |
Zimmermann MartineFirst filing | Director | Sale | 1,200 | $342K | Sep 14 | +12.2% | SEC ↗ |
| CLO & Secretary | Sale | 5,000 | $1.4M | Sep 8 | +9.0% | SEC ↗ | |
| Director | Sale | 7,138 | $2.1M | Aug 14 | — | SEC ↗ | |
Espinoza OctavioFirst in 5 months | Chief Financial Officer | Sale | 31,641 | $9.2M | Aug 14 | — | SEC ↗ |
| CLO & Secretary | Sale | 5,000 | $1.4M | Aug 4 | — | SEC ↗ | |
| CLO & Secretary | Sale | 5,000 | $1.6M | Jul 6 | — | SEC ↗ | |
| Director | Sale | 2,145 | $545K | Jun 18 | — | SEC ↗ | |
| Director | Sale | 6,461 | $1.7M | Jun 15 | — | SEC ↗ | |
| Director | Sale | 4,591 | $1.2M | Jun 12 | — | SEC ↗ | |
| Director | Sale | 500 | $125K | Jun 12 | — | SEC ↗ | |
| Director | Sale | 4,500 | $1.1M | Jun 12 | — | SEC ↗ | |
| CLO & Secretary | Sale | 5,000 | $1.1M | Jun 2 | — | SEC ↗ | |
| Director | Sale | 467 | $108K | May 15 | — | SEC ↗ | |
| Director | Sale | 459 | $103K | May 15 | — | SEC ↗ | |
| Director | Sale | 1,575 | $352K | May 15 | — | SEC ↗ | |
| CLO & Secretary | Sale | 5,000 | $1.2M | May 5 | — | SEC ↗ | |
| CLO & Secretary | Sale | 5,000 | $1.0M | Apr 2 | — | SEC ↗ | |
| Director | Sale | 467 | $94K | Apr 2 | — | SEC ↗ | |
LAMATTINA JOHN LFirst in 5 months | Director | Sale | 2,161 | $434K | Mar 31 | — | SEC ↗ |
| Director | Sale | 1,000 | $208K | Mar 25 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 3,057 | $688K | Mar 13 | — | SEC ↗ | |
Reardon AndrewFirst filing | CLO & Secretary | Sale | 5,000 | $1.0M | Mar 6 | — | SEC ↗ |
| Chief Financial Officer | Sale | 13,423 | $2.8M | Mar 6 | — | SEC ↗ | |
Sabba Stephen LFirst filing | Director | Sale | 2,034 | $410K | Mar 5 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading LGND 7 all-time
- DRep. Gilbert CisnerosPurchase$1,001 - $15,0002026-05-29
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-05-29
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-01-15
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002026-01-05
- DRep. Katherine M. ClarkOther$1,001 - $15,0002020-10-22
- DRep. Katherine M. ClarkPurchase$1,001 - $15,0002020-04-03
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does LGND have?
LIGAND PHARMACEUTICALS INC (LGND) has 51 SEC Form 4 filings (205 transaction rows) in the rolling 365-day window, disclosed by 9 distinct insiders. Most recent filing: Oct 6, 2026.
When was the most recent SEC Form 4 filing for LGND?
The most recent Form 4 filing for LGND on Tracefour is dated Oct 6, 2026.
Who is the most active insider at LGND?
The most active SEC Form 4 filer at LGND in the rolling window is Director KOZARICH JOHN W, with 9 filings.
What is the net insider flow at LGND over the last 6 months?
Over the trailing 180 days, insiders at LGND have net sold $25.1M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at LGND in the current window?
Inside the rolling window, insiders at LGND bought $0 and sold $34.7M based on SEC Form 4 filings.
Can I get alerts for LGND insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at LIGAND PHARMACEUTICALS INC (LGND). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
LIGAND PHARMACEUTICALS INC is in the Healthcare sector.